TrialAmerican journal of respiratory and critical care medicine2020

Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial.

Andrew I Ritchie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.